Key Events This Week
27 Apr: Stock dips 1.05% despite Sensex rising 1.14%
28 Apr: Sharp rebound with 3.97% gain, bucking Sensex decline
29 Apr: Mixed technical signals emerge amid price momentum shift
30 Apr: Upgrade to Hold rating announced; stock gains 1.42%

Gujarat Themis Biosyn Ltd Upgraded to Hold on Technical and Quality Improvements
2026-04-30 08:12:14Gujarat Themis Biosyn Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality. The upgrade, effective from 29 April 2026, follows a period of mixed performance but notable resilience in a challenging pharmaceuticals sector environment.
Read full news article
Gujarat Themis Biosyn Ltd Shows Mildly Bullish Momentum Amid Technical Shifts
2026-04-30 08:02:53Gujarat Themis Biosyn Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This transition is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector.
Read full news article
Gujarat Themis Biosyn Ltd Sees Mixed Technical Signals Amid Price Momentum Shift
2026-04-29 08:03:04Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a robust day gain of 3.97%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, warranting a nuanced analysis for investors.
Read full news article
Gujarat Themis Biosyn Ltd Surges 9.74% to Day's High of Rs 360.75 — Outperforms Sector by 10.65 Percentage Points
2026-04-24 10:45:58The Sensex declined by 1.07% on 24 Apr 2026, while Gujarat Themis Biosyn Ltd surged 9.74%, outperforming its Pharmaceuticals & Biotechnology sector by 10.65 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market environment.
Read full news article
Gujarat Themis Biosyn Ltd is Rated Sell
2026-04-20 10:10:03Gujarat Themis Biosyn Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article








